Journal articleJ Exp Clin Cancer Res2018
Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
- Journal
- J Exp Clin Cancer Res
- Published
- 24 July 2018
- Citations
- 18
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try